RxDoctor Payments Data

Andrea Carpenter

Family · Mantachie, MSNPI 1780169557

Payments from drug & device makers

$1,865in general payments, 2019–2025

Across 115 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$365
  • Novo Nordisk$334
  • AstraZeneca$329
  • Lilly USA, LLC$174
  • Amgen$86
  • Corcept Therapeutics$78
  • plus $498 from 15 others

What the payments were for

  • Food & beverage$1,865100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,865 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$69,481
Medicare patients
184
Services billed
2,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide91$152,315
VascepaIcosapent Ethyl47$45,026
Repatha SureclickEvolocumab35$38,141
FarxigaDapagliflozin Propanediol30$38,085
TrulicityDulaglutide15$31,515
OzempicSemaglutide15$24,998
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,337
Xigduo XrDapaglifloz Propaned/Metformin12$6,571
LinzessLinaclotide11$5,793
Esomeprazole Magnesium30$1,502
Duloxetine Hcl44$1,189
Gabapentin102$1,176
Cefdinir33$777
Omeprazole83$679
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$174$183,830106 claims
AstraZenecaFarxiga$329$38,08530 claims
Novo NordiskOzempic$334$24,99815 claims
GSKTrelegy Ellipta$60$10,33714 claims
AbbVieLinzess$48$5,79311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,007 family providers in Mississippi.

Other family in Mantachie

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →